David Lehr Research Award
Forecasted
David Lehr Research Award supports pharmacology investigators with funding for preclinical or clinical research directed toward improving human health, administered by ASPET.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Award deadline)
Funding Amounts: Research funding for preclinical or clinical research
Summary: Supports pharmacology investigators conducting preclinical or clinical research directed toward improving human health.
Key Information: Investigators must be aged 45 or older.
Description
The David Lehr Research Award is administered by the American Society for Pharmacology and Experimental Therapeutics (ASPET) as part of its Scientific Achievement Awards program. It is intended to extend funding for preclinical or clinical research directed toward improving human health. Its area of specialty is Clinical Pharmacology / General, and it is intended for investigators aged 45 or older.
The award sits within ASPET’s broader effort to recognize accomplishments in specific areas of pharmacology and contributions to the discipline generally. It is supported by an endowment from Mrs. Lisa Lehr in honor of her husband, the late Dr. David Lehr, former chair of the Department of Pharmacology at New York Medical College.
